Morning Briefing
Summaries of health policy coverage from major news organizations
Participation Of Big Pharma Companies Critical To Success Of Drug Patent Pools
In this post in the Huffington Post's "Impact" blog, David de Ferranti, president of the Results for Development Institute, and Robert Hecht, managing director at the Institute, examine whether patent pools could help increase access to AIDS drugs among the world's poor, writing, "AIDS program managers and advocates must pursue all measures that can keep the cost of treatment low and affordable. In addition to the actions that are already being taken -- like having African governments and donors buy AIDS drugs in bulk from suppliers in order to obtain better prices -- could a 'patent pool' for new drugs help to make AIDS treatment more accessible?"
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
